Cambria Pharmaceuticals
Latest round
- Series A
Last raised
- Apr 2008
Total raised
- $5.4M
Investors
- 2
About Cambria Pharmaceuticals
Cambria Pharmaceuticals is a US-based biopharmaceutical company that operates as a manufacturer of treatments for disabling neurological disorders.
Who invested in Cambria Pharmaceuticals
2 investors across 1 round
See all investors in Cambria Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 22, 2008
Amount
$5.4M
Investors
Questions about Cambria Pharmaceuticals
Who invested in Cambria Pharmaceuticals?
Cambria Pharmaceuticals has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cambria Pharmaceuticals raised?
Cambria Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Cambria Pharmaceuticals last raise money?
Cambria Pharmaceuticals's most recent round on record is a Series A, in Apr 2008.
What does Cambria Pharmaceuticals do?
Cambria Pharmaceuticals is a US-based biopharmaceutical company that operates as a manufacturer of treatments for disabling neurological disorders.
Where is Cambria Pharmaceuticals headquartered?
Cambria Pharmaceuticals is headquartered in Cambridge, US.
Which VCs invest in companies like Cambria Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Cambria Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Cambria Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.